Effect of white egg and Niacin on hemodialysis patients

Evaluation the efficacy of Dietary Pasturized egg white with and without Niacinamide for phosphorus control in End Stage Renal Disease patients on Haemodialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016102226390N5

Enrollment

Registered

2016-10-27

Start date

2016-12-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient under hemodialysis. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention: patient will recive Pasteurized whit egg for 6 weeks as 24gram protein. Intervention 2: Intervention: Patients will recieve Niacin 600 mg for 6 weeks. Intervention 3: Int

Treatment - Drugs

Intervention: patient will recive Pasteurized whit egg for 6 weeks as 24gram protein

Intervention: Patients will recieve Niacin 600 mg for 6 weeks

Intervention: patient will recieve Pasteurized white egg and (24 gram protein) and Niacin 600 mg for 6 weeks

Control: continue conventional treatmen along with intervention group

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Hemofialysis patient; Tendency for participating in reserch Exclusion criteria: Change in life Style; dietary regimen change, physical activity and tension; No tendency for keeping on

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Calcium. Timepoint: befor and after. Method of measurement: Lab Kit.;Phosphrous. Timepoint: befor and after. Method of measurement: Lab Kit.;Albumin. Timepoint: befor and after. Method of measurement: Lab Kit.;Parathormon. Timepoint: befor and after. Method of measurement: Lab Kit.;Fibroblast Growth Factor 23. Timepoint: befor and after. Method of measurement: Lab Kit.	—

Secondary

Measure	Time frame
Wieght. Timepoint: befor and after. Method of measurement: sensitive Balance.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Javadian

Shahrekord University of Medical Sciences

javadianp@gmail.com+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026